نتایج جستجو برای: پروتئین brca1

تعداد نتایج: 26041  

Journal: :Cancer research 2008
Elizabeth M Swisher Wataru Sakai Beth Y Karlan Kaitlyn Wurz Nicole Urban Toshiyasu Taniguchi

Although ovarian carcinomas with mutated BRCA1 or BRCA2 are sensitive to platinum compounds, such carcinomas eventually develop platinum resistance. Previously, we showed that acquired resistance to cisplatin in BRCA2-mutated tumors can be mediated by secondary intragenic mutations in BRCA2 that restore the wild-type BRCA2 reading frame. Here, we show that secondary mutations of BRCA1 also occu...

2009
Huchun Li Masayuki Sekine Seyha Seng Shalom Avraham Hava Karsenty Avraham

BACKGROUND BRCA1 is a key regulatory protein participating in cell cycle checkpoint and DNA damage repair networks. BRCA1 plays important roles in protecting numerous cellular processes in response to cell damaging signals. Transforming growth factor-beta (TGF-beta) is a potent regulator of growth, apoptosis and invasiveness of tumor cells. TFG-beta activates Smad signaling via its two cell sur...

Journal: :Molecular and cellular biology 2001
L J Huber T W Yang C J Sarkisian S R Master C X Deng L A Chodosh

Both human and mouse cells express an alternatively spliced variant of BRCA1, BRCA1-Delta11, which lacks exon 11 in its entirety, including putative nuclear localization signals. Consistent with this, BRCA1-Delta11 has been reported to reside in the cytoplasm, a localization that would ostensibly preclude it from playing a role in the nuclear processes in which its full-length counterpart has b...

2012
Jos Jonkers

Author’s Affi liation: Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands Corresponding Author: Jos Jonkers, Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Phone: 31-20-5122000; Fax: 31-20-5122050; E-mail: [email protected] doi: 10.1158/2159-8290.CD-12-0186 ©2012 American Associati...

2016
Angel Chao Ting-Chang Chang Nina Lapke Shih-Ming Jung Peter Chi Chien-Hung Chen Lan-Yan Yang Cheng-Tao Lin Huei-Jean Huang Hung-Hsueh Chou Jui-Der Liou Shu-Jen Chen Tzu-Hao Wang Chyong-Huey Lai

Germline and somatic BRCA1/2 mutations define a subset of patients with ovarian cancer who may benefit from treatment with poly (ADP-ribose) polymerase inhibitors. Unfortunately, data on the frequency of BRCA1/2 germline mutations in Taiwanese patients with ovarian cancer are scarce, with the prevalence of somatic mutations being unknown. We aim to investigate the occurrence of BRCA1/2 mutation...

Journal: :Cancer research 2002
Lodewyk F A Wessels Tibor van Welsem Augustinus A M Hart Laura J van't Veer Marcel J T Reinders Petra M Nederlof

In approximately 70% of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or BRCA2 germline mutations cannot be identified with the current screening regime. Therefore, we used data mining to identify a somatic genetic signature to differentiate BRCA1 mutation carriers from non-BRCA1 carriers based on the genetic characteristics of their breast carcinomas. Fo...

Journal: :Journal of medical genetics 2012
Amanda B Spurdle Phillip J Whiley Bryony Thompson Bingjian Feng Sue Healey Melissa A Brown Christopher Pettigrew Christi J Van Asperen Margreet G E M Ausems Anna A Kattentidt-Mouravieva Ans M W van den Ouweland Annika Lindblom Maritta H Pigg Rita K Schmutzler Christoph Engel Alfons Meindl Sandrine Caputo Olga M Sinilnikova Rosette Lidereau Fergus J Couch Lucia Guidugli Thomas van Overeem Hansen Mads Thomassen Diana M Eccles Kathy Tucker Javier Benitez Susan M Domchek Amanda E Toland Elizabeth J Van Rensburg Barbara Wappenschmidt Åke Borg Maaike P G Vreeswijk David E Goldgar

BACKGROUND Clinical classification of rare sequence changes identified in the breast cancer susceptibility genes BRCA1 and BRCA2 is essential for appropriate genetic counselling of individuals carrying these variants. We previously showed that variant BRCA1 c.5096G>A p.Arg1699Gln in the BRCA1 transcriptional transactivation domain demonstrated equivocal results from a series of functional assay...

2010
Brian J. Kluk Yebo Fu Trina A. Formolo Lei Zhang Anne K. Hindle Yan-gao Man Robert S. Siegel Patricia E. Berg Chuxia Deng Timothy A. McCaffrey Sidney W. Fu

INTRODUCTION Several lines of evidence point to an important role for BP1, an isoform of DLX4 homeobox gene, in breast carcinogenesis and progression. BRCA1 is a well-known player in the etiology of breast cancer. While familial breast cancer is often marked by BRCA1 mutation and subsequent loss of heterozygosity, sporadic breast cancers exhibit reduced expression of wild type BRCA1, and loss o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
K Yoshikawa K Honda T Inamoto H Shinohara A Yamauchi K Suga T Okuyama T Shimada H Kodama S Noguchi A F Gazdar Y Yamaoka R Takahashi

BRCA1 is a tumor suppressor gene that is responsible for hereditary breast and ovarian cancer syndrome. To clarify the possible involvement of the BRCA1 protein in mammary carcinogenesis in sporadic and hereditary forms, we have analyzed the BRCA1 protein expression pattern in five breast epithelial cell lines, including a BRCA1-deficient cell line, and 162 breast cancer tissue samples [includi...

2013
Aya Masaoka Natalie R. Gassman Julie K. Horton Padmini S. Kedar Kristine L. Witt Cheryl A. Hobbs Grace E. Kissling Keizo Tano Kenjiro Asagoshi Samuel H. Wilson

The breast cancer 1 (BRCA1) protein is a tumor suppressor playing roles in DNA repair and cell cycle regulation. Studies of DNA repair functions of BRCA1 have focused on double-strand break (DSB) repair pathways and have recently included base excision repair (BER). However, the function of BRCA1 in BER is not well defined. Here, we examined a BRCA1 role in BER, first in relation to alkylating ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید